Extracellular HMGB1 as a therapeutic target in inflammatory diseases

U Andersson, H Yang, H Harris - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: High-mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that
promotes inflammation when released extracellularly after cellular activation, stress …

HMGB1 and repair: focus on the heart

L Pellegrini, E Foglio, E Pontemezzo, A Germani… - Pharmacology & …, 2019 - Elsevier
High-mobility group box 1 (HMGB1) is one of the most abundant proteins in eukaryotes and
the best characterized damage-associated molecular pattern (DAMP). The biological …

Johnny on the spot-chronic inflammation is driven by HMGB1

CM Gorgulho, GG Romagnoli, R Bharthi… - Frontiers in …, 2019 - frontiersin.org
Although much has been made of the role of HMGB1 acting as an acute damage associated
molecular pattern (DAMP) molecule, prompting the response to tissue damage or injury, it is …

Organ-specific biomarkers in lupus

H Wu, J Zeng, J Yin, Q Peng, M Zhao, Q Lu - Autoimmunity reviews, 2017 - Elsevier
Systemic lupus erythematosus (SLE) is a complex and highly heterogeneous disease, which
affects multiple organs, including joints, skin, kidneys, heart, hematopoietic system, and …

H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome

P Ruscitti, P Cipriani, P Di Benedetto… - Clinical & …, 2018 - academic.oup.com
Macrophage activation syndrome (MAS) is hyperinflammatory life-threatening syndrome,
associated typically with high levels of serum ferritin. This is an iron storage protein including …

Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome

V Manganelli, S Truglia, A Capozzi… - Frontiers in …, 2019 - frontiersin.org
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease characterized
by arterial and/or venous thrombosis, pregnancy morbidity in the presence of circulating …

Urine biomarker score captures response to induction therapy with lupus nephritis

EM Cody, SE Wenderfer, KE Sullivan, AHJ Kim… - Pediatric …, 2023 - Springer
Abstract Background The Renal Activity Index for Lupus (RAIL) consists of urine protein
assessment of neutrophil gelatinase–associated lipocalin, kidney injury molecule-1 …

Understanding the role of exosomal lncRNAs in rheumatic diseases: a review

R Chen, D Zhou, Y Chen, M Chen, Z Shuai - PeerJ, 2023 - peerj.com
Rheumatic diseases, a group of diseases whose etiology is still unclear, are thought to be
related to genetic and environmental factors, leading to complex pathogenesis. Based on …

Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis

HY Ma, S Chen, WD Cao, CT Min - Renal failure, 2021 - Taylor & Francis
Purpose Accumulative studies showed that tumor necrosis factor (TNF)-like weak inducer of
apoptosis (TWEAK) was up-regulated in the blood and urine from patients diagnosed with …

[PDF][PDF] 血清炎性细胞因子水平与糖尿病肾病病情进展的关系

陈娟, 高鹏霞, 石敏, 张红 - 中华肾脏病杂志, 2019 - cjn.org.cn
目的探讨血清高迁移率族蛋白B1 (HMGB1), 胰岛素样生长因子1 (IGF⁃ 1) 和血管内皮生长因子
165 (VEGF165) 水平与糖尿病肾病(DN) 病情进展的相关性. 方法选择2016 年1 月至2018 年1 …